A B S T R A C T Alterations in the percent and absolute number of thymus-derived (T) and bursa-equivalent (B) lymphocytes in peripheral blood were followed in 10 patients treated with antithymocyte globulin, prednisone, and azathioprine after cardiac transplantation. During the 1st postoperative wk the percent of T cells dropped below 10% in almost all cases (normal range, 65-91%) with a concomitant rise in the percent of B cells. However, the absolute T-and B-cell counts were both markedly depressed (< 200 cells/mm8). During the 7-wk postoperative period the percent of T cells rose to 45-60% and the absolute count rose from 100 to 350 cells/mm' (normal range, 1,092-2,400 cells/mm3). Although the percent of B cells was elevated (35-50%) during this period, the absolute B-cell count remained below the range of normals (268-640 cells/mm3). Follow-up of long-term survivors (3-60 mo postoperative) showed a continued marked T (467 cells/mm3) and B (95 cells/mm3) lymphocytopenia. Chronological relationships between the percent and absolute T-cell count and episodes of graft rejection in individual patients are discussed as possible adjuncts in the prediction of rejection crises.
INTRODUCTION
Prolonged survival of renal and cardiac allografts in man has been achieved using a variety of immunosuppressive regimens (1) (2) (3) (4) . Determination of the dosage, time course, and type of immunosuppressive agents has been mainly empirical and related to the presence or absence of graft rejection. Few immunological parameters have been used to assess the impact of immunoDr. Strober is the recipient of National Institutes of Health Career Development Award AI 70018. Dr. Stinson is an Established Investigator of the American Heart Association.
Received for publication 3 November 1975 and in revised form 8 March 1976. suppression between rejection episodes or to predict the onset of rejection crises.
Thymus-derived (T) lymphocytes play a central role in acute rejection of organ transplants (5) (6) (7) . Recently, several techniques for the identification and quantitation of T lymphocytes in human peripheral blood have been reported. The present study was carried out to determine percent and absolute number of T cells in the peripheral blood of patients treated with a combination of antithymocyte globulin (ATG),' prednisone, and azathioprine after cardiac transplantation. It was expected that the level of T cells in the peripheral blood might be a useful aid in evaluating the efficacy of immunosuppressive treatment and in predicting rejection episodes. In addition, the effects of chronic immunosuppressive therapy on T and bursa-equivalent (B) cells were compared to determine the target cell specificity of the treatment.
METHODS
Patients. 10 patients undergoing cardiac transplantation because of advanced incapacitating cardiac disease were studied. Six patients presented severe coronary artery disease complicated by irremediable left ventricular dysfunction, and four patients presented idiopathic cardiomyopathy. Nine of the patients were men, and the mean patient age was 36 yr (range, yr). Preoperative medical treatment included digoxin and various diuretic drugs in all patients. Postoperative drug therapy (excluding immunosuppressive agents) included diuretics, warfarin sodium, and dipyridamole. The operative techniques utilized for cardiac transplantation have previously been described in detail (8) .
16 of the 21 rejection episodes documented in the group of 10 patients occurred during the first 35 postoperative days. There was one death which occurred on day 48. Patients were discharged from the hospital between postoperative days 45-101, and were not hospitalized thereafter unless a rejection episode intervened.
Diagnosis of acute cardiac graft rejection. Methods for 1Abbreviations used in this paper: ATG, antithymocyte globulin, B, bursa equivalent; T, thymus derived.
The Journal of Clinical Investigation Volume 58 July 1976.212-220 212 the diagnosis of cardiac allograft rejection in man have been described previously (9, 10) . In brief, the clinical diagnosis of graft rejection was predicated on a decrease, exceeding 20 percent of baseline, in the algebraic sum of QRS voltages in standard electrocardiographic leads I, II, III, V', and V6 or upon the development of a new early or late diastolic gallop rhythm, indicative of decreased ventricular compliance. All episodes of diagnosed and treated graft rejection in the patients included in ithis report, however, were confirmed histologically by transvenous endomyocardial biopsy (10) . Typical morphological features indicative of acute rejection in such biopsy specimens include interstitial and intracellular (myocyte) edema, perivascular and interstitial infiltration with mononuclear cells containing methyl green pyronine-positive cytoplasm, endocardial thickening and cellular infiltration, and occasionally areas of myocyte destruction with fibrous replacement.
Imimunosuppression. Immunosuppressive therapy included azathioprine, prednisone, and ATG of rabbit origin in all patients. All recipients received a loading dose of azathioprine, 4-5 mg/kg orally, immediately before operation, and maintenance doses of 2-3 mg/kg per day postoperatively, as determined by the peripheral leukocyte count. Methylprednisolone, 5 mg/kg, was given intraoperatively to all patients, and maintenance oral prednisone treatment was begun on the lst postoperative day in a dose of 1.5 mg/kg, and gradually decreased to 1.0 mg/kg daily by the end of the 2nd postoperative wk.
Antihuman thymocyte globulin was produced in New Zealand white rabbits by a modification of the method of Davis et al. (11 (12) were determined for each pool and averaged 1/ 40,000. Dosage of ATG was regulated according to the rosette inhibition titer of -the preparation used; 1-ml of a 50 mg protein/ml globulin preparation was considered to contain a number of "units" equal to the reciprocal of the rosette inhibition titer (RIT units). Each dose, administered intramuscularly, consisted of 4,000 U/kg. The schedule of administration utilized in all patients consisted of six initial doses on postoperative days 0, 1, 2, 4, 6, and 8. Thereafter, ATG was administered only during some of the diagnosed acute rejection episodes in courses of six doses (daily for 3 days, then every other day for three doses).
Assay for T cells in the peripheral blood. T lymphocytes were identified by an in vitro cytotoxicity test using a specific anti-T-cell serum (13) . Anti-T-cell serum was prepared by immunizing goats with thymus cells obtained from children undergoing cardiac surgery. The crude antithymocyte serum was extensively absorbed with human erythrocytes and a lymphoblastoid cell line which carries surface immunoglobulin as judged by immunofluorescent staining.
We have previously shown that these absorbed antisera kill less than 10%o of a suspension of pure Ig-bearing human peripheral blood lymphocytes obtained by automatic separation on a fluorescence activated cell sorter (13) . In addition, the specificity of each batch of antiserum is standardized by measuring the percent kill of pure suspensions of Erosette forming and nonrosette forming cells from normal donors. E-rosette formation is performed according to Bentwich et al. (14) , and rosettes are separated on a Ficoll- (15) .
Blood samples. Blood samples (10-20-ml heparinized blood) were assayed two to three times per wk for each patient. Data is presented for 7 wk postoperatively, since many patients were discharged from the hospital after that time. Despite severe lymphopenia in most patients, 100-400 cells were counted on each occasion to determine the percent of T cells.
RESULTS
Percent and absolute numiitber of T and B ceUs in normiial controls and in patien-ts with congestive heart failure. seven patients showed an absolute T-cell count below the normal range. The mean percent (14%) and absolute number (358/mm3) of B cells were significantly below normal (P < 0.01), as judged by the Student's t test for unpaired data.
Alterations in T and B lymphocytes during immediate postoperative period. Fig. 1 (Fig. 1) . However, the percent of B cells remained elevated in some cases while the percent of T cells rebounded during the 2nd week. The sum of the percent of T and B cells in these cases was sometimes greater than 150%.
In contrast, the sum of the percent of T and B cells in normal controls never exceeded 105%.
The markedly elevated sum of the percent of T and B cells noted in some patients was transient (3-5 days) and infrequent, but appeared to be related to concurrent or recent treatment with ATG. A possible explanation for this finding is that treatment with ATG results in the coating of some T cells with human immunoglobulin. The latter cells would be spuriously identified as B cells since they bear human Ig on their surface. To test this point, peripheral blood lymphocytes from two normal controls were typed for T and B cells before and after incubation for 1 h at 37°C in vitro with serum from two heart transplant patients receiving ATG. Table III shows that in three out of four cases the percent of B cells rose substantially after incubation, and the sum of the percent of T and B cells exceeded 115%. Measured percent of T cells was not significantly different.
Although the percent of B lymphocytes was elevated during the first 2 wk, the absolute B lymphocyte count was depressed in almost all cases (< 200 cells/mm3) (Fig. 1) . Combined early postoperative therapy, therefore, produces both T-and B-cell lymphopenia, and affects the T cells proportionately more severely than the B cells.
Changes in the percent and absolute number of T cells in the peripheral blood during the 7-wk postoperative period. Fig. 2 shows the weekly mean percent of T cells in the peripheral blood of the 10 patients during the 7-wk postoperative period. The percent rose from 35 to 62 during the 1st to the 3rd week, and varied between 45 and 60% thereafter. The absolute number of T cells rose gradually from 100 cells/mm3 to 350 cells/mm' during the 1st to 7th weeks. However, the T-cell level at 7 wk was still fivefold decreased as compared to normals (Fig. 2) .
Percent and absolute number of B cells in the peripheral blood during the 7-wk postoperative period. Fig. 3 shows that the mean percent of B lymphocytes of all 10 patients was elevated during the entire 7-wk period. The mean percent of T (71%) and B (26%) cells in these patients was similar to that of normals. However, Relationship between the percent and absolute count of T lymphocytes and rejection episodes. Fig. 4 shows the time course of immunosuppressive therapy, rejection episodes, and percent and absolute T cells in two patients. These patients are not representative of all 10 cases, since in some instances, rejection episodes were preceded by a marked rise in the percent and absolute number of T cells, as in the second episode illustrated in Fig. 4b . In other instances, a less well-defined rise or no rise at all was noted in the 5-day period preceding a rejection episode (Fig. 4a) . Institution of high-dose methylprednisolone (1.0 g daily, intravenously for 2-3 days) during rejection crises was frequently followed by an abrupt decrease in the percent and absolute number of circulating T cells (Figs. 4a and 4b) . The continued marked fluctuation in the percent of T cells noted during periods of stable therapy (Fig. 4a) was seen in several patients, and could not be related to other clinical or laboratory parameters.
Although statistically significant correlations were not found between the kinetics of the rises in the level of T cells and rejection episodes, it is notewor,thy that patients with more than 400 T cells/mm' recorded during the first 3 wk post-transplantation sustained twice as many rejection episodes as those with levels consistently below 400 T cells/mm3.
DISCUSSION
Alterations in the percent and absolute number of T and B lymphocytes in the peripheral blood were assessed in 10 patients treated with ATG, prednisone, and azathioprine after cardiac transplantation. ATG was given daily for the first 3 days and then every other day for 3 additional days. ATG was subsequently discontinued U . (17) . ATG-coated T cells could therefore bind anti-ATG antibodies to the cell surface and "masquerade" as B cells.
Although the immunosuppressive regimen showed specificity for T-cell depletion, as judged by alterations in the percent of T and B cells, the absolute number of both T and B cells was markedly decreased during the 1st postoperative wk. In almost all cases, the T-cell count was below 200 cells/mm3, and the B-cell count was similarly depressed. However, the depletion of T cells was considerably more profound than B cells, since the normal absolute T-cell count is four times greater than that of B cells. Similar acute alterations in the percent and absolute numbers of T and B cells in the blood of normal volunteers have been induced by administration of high doses of prednisone alone for short periods of time (18, 19) .
However, a recent study of alterations in peripheral blood T cells in patients receiving renal allografts suggests that ATG, prednisone, and azathioprine produce a more profound T-cell lymphopenia than prednisone and azathioprine alone (20) . T-cell values may be spuriously low in the latter study, since the sheep erythrocyte rosette technique was used. ATG has been shown to block rosette formation, and coating of the T-cell surface may persist long after ATG has been cleared from the serum.
During the 2nd week after transplantation the percent of T cells rose from 35 to 62%, and varied between 45 and 60% thereafter. The absolute T-cell count rose from 100 to 350 cells/mm3. The latter figure is still fivefold decreased as compared to that of normals. Although the percent of B cells was elevated (35-50%) during the entire study, the mean absolute B-cell count remained below the range of normals. However, the B-cell level at 50 days postoperative (-200 cells/mm3) was not significantly different from that of nonimmunosuppressed patients with cardiac failure (258 cells/mm3). The selective T-cell depletion noted during the 1st postoperative wk is, therefore, maintained through the 7th postoperative wk.
Long-term follow-up of patients 3-60 mo after transplantation showed that although the mean percent of T (71%) and B (26%) cells had returned to normal, the absolute T-cell (467 cells/mm3) and B-cell (95 cells/ mm3) counts were considerably decreased. A severe Bcell depletion (< 50 cells/mm3) was observed in one-half of these patients. This suggests that the target cell specificity of the present long-term immunosuppressive regimens (i.e. azathioprine and prednisone) may not be satisfactory.
The chronological relationship between the percent and absolute count of T cells and rejection crises was variable. In some instances, there was a clear-cut rise in both parameters in the 5-day period preceding a biopsy-proven rejection crisis (Fig. 4) . In other cases, rejection episodes were not preceded by rises. Statistical analysis of the time intervals between rejection episodes and peaks in the percent and absolute T-cell count show no significant chronological relationship in the 10 patients analyzed. However, patients with absolute T-cell counts above 400 cells/mm3 during the first 3 wk postoperative had twice as many rejection episodes as those below this level.
The greater incidence of rejection episodes in patients with high T-cell levels and those instances of rejection crises preceded by rises in the T-cell levels suggest that measurement of T-cell levels in transplant patients may Alterations in T and B Lymphocytes in Heart Transplant Patients 219 be a useful adjunctive diagnostic aid in determining adequacy of immunosuppression.
